VC firm
Digitalis Ventures
Also known as Companion Fund
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- New York, NY, United States
- Assets under management
- $862MForm ADV private fund GAV, as of 2026-03-30Source (opens in a new tab)
- Funds
- 5
- Legal name
- Digitalis Ventures LLC
- digitalisventures.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Blog (opens in a new tab)
- Team page (opens in a new tab)
Claim, correct or request removal
Record updated 29 September 2026
About
Digitalis Ventures invests in solutions to unmet needs in biomedicine and health.
Investment approach
- Thesis
- We provide venture capital to early-stage companies across life sciences, health technologies, and animal health, and we support them throughout their development.Source (opens in a new tab)
- Investing status notes
- Digitalis Ventures invests in solutions to unmet needs in biomedicine and health.
Funds
- COMPANION FUND I LLC
- Main fund
- DIGITALIS MARS HEALTH FUND II, LLC
- Main fund
- DIGITALIS MARS COMPANION FUND II LLC
- Main fund
- MARS HEALTH FUND I, LLC
- Main fund
- DPG FUND I LLC
- Main fund
SEC registration
- Registered adviser
- DIGITALIS VENTURES, LLC
- CRD number
- 283347 (opens in a new tab)
- SEC file number
- 802-107493
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $862Mas of 2026-03-30
- Private funds reported
- 5
- Principal office
- NEW YORK, NY, United States
Locations
- Headquarters
- New York, NY, United States
Programs
- Accelerator
- Leap Venture Studio (opens in a new tab)
- Newsletter
- Notes on Animal Health (opens in a new tab)sent bimonthly
Loading relationship preview